Improving Access to Care


Providing access to care for all is a significant and complex global challenge. In Canada in particular, there are complex regulatory, legal and health-related issues surrounding the distribution of prescription medicines. While we do not donate medicines directly to individuals, we do have programs that help get our medicines to patients who need them. In communities with limited healthcare infrastructure and significant unmet public health need, we partner with others to strengthen healthcare frameworks and capabilities and donate medication and supplies.   


Patient Assistance Program

In Canada, our AstraZeneca Patient Assistance Program is available to patients in financial need who meet the eligibility requirements.  Patients interested in this program should ask their doctor's office to contact our Medical Information Department at 1-800-668-6000 and request a Drug Request form.

Global Access to Medicine Programs

Healthy Heart Africa: Healthy Heart Africa is a program launched by AstraZeneca
in October 2014. It aims to support local health systems in Africa by increasing awareness of the symptoms and risks of hypertension and by offering education, screening, reduced-cost treatment and control.

Cambodia Breast Cancer Initiative: Breast cancer related mortality remains devastatingly high in the developing world due to limited awareness of self-screening practices, low access to diagnostic technology and cost of oncology medicines. The Cambodia Breast Cancer Initiative is an ongoing partnership between AstraZeneca, AmeriCares and Sihanouk Center of Hope (SHCH) Hospital in Phnom Pen, Cambodia to strengthen existing treatment services while expanding in scale to reach additional patients. AstraZeneca provides free medicine to postmenopausal breast cancer patients in the Center of HOPE’s treatment cohort and supports the education of Cambodian women about the importance of early detection and prompt care-seeking.

Breast Cancer in Africa: Breast cancer is a leading cause of cancer death among women in South Africa. AstraZeneca is collaborating with a group of local organizations to help raise breast cancer awareness, increase early diagnosis, and improve access to treatment and effective support networks. More than 1.6 million women have been reached by trained volunteers across the country. South Africa’s Foundation for Professional Development is also providing accredited courses in cancer diagnosis, treatment and care to healthcare professionals.

Drug Donations

For more than 25 years, AstraZeneca has been a proud partner of Health Partners International of Canada (HPIC), a Montréal-based charitable organization that provides much needed medicines, vaccines, medical supplies and devices to humanitarian or disaster relief missions in developing countries. Our products are included in HPIC’s Humanitarian Mission Packs which contain assorted essential medicines and medical supplies that can treat up to 600 children and adults. We are also proud to be a major contributor to HPIC’s Capacity Building and Access to Medicines Project in Afghanistan and a Founding Contributor to the Jake Epp Development Fund.  To date, we have provided more than $25 million in medicines to HPIC relief efforts.

If you are a healthcare professional seeking medicine for an overseas medical mission, you can visit the HPIC website to request a Humanitarian Mission Pack for short-term overseas medical work or to make a special request for a particular supply of medicines. Please contact HPIC directly at info@hpicanada.ca or phone (1-800-627-1787) or visit their website.

AstraZeneca is committed to ensuring that patients receive appropriate medicine donations through reputable partners and that these donations are of the highest quality. To that end, AstraZeneca aligns our product donations with both the World Health Organization (WHO) “Guidelines for Medicine Donations” as revised, and the Partnership for Quality Medical Donations (PQMD) “Guidelines for Quality Medical Product Donations” as revised.


AstraZeneca and HPIC